Correction to “Outcomes of patients with relapsed or refractory primary mediastinal B‐cell lymphoma treated with anti‐CD19 CAR‐T cells: CARTHYM, a study from the French national DESCAR‐T registry”

Read full text Summarise with VIRAT
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

[This corrects the article DOI: 10.1002/hem3.70091.].

Fields of Study & Subjects

CAR-T cell therapy research Lymphoma Diagnosis and Treatment Cutaneous lymphoproliferative disorders research

Publication details

Journal / source
HemaSphere
Volume
10
Issue
3
Pages
e70335–e70335
Publication date
1 March 2026
Language
EN